Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: Response to glucocorticoid (GC) monotherapy in the initial phase of remission induction treatment in childhood acute lymphoblastic leukemia (ALL) represents important biomarker of prognosis and outcome. We aimed to study variants in several pharmacogenes (NR3C1, GSTs and ABCB1) that coul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiol Oncol
Main Authors: Gasic, Vladimir, Zukic, Branka, Stankovic, Biljana, Janic, Dragana, Dokmanovic, Lidija, Lazic, Jelena, Krstovski, Nada, Dolzan, Vita, Jazbec, Janez, Pavlovic, Sonja, Kotur, Nikola
Formato: Artigo
Idioma:Inglês
Publicado em: Sciendo 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6137363/
https://ncbi.nlm.nih.gov/pubmed/30210047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2018-0034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados